Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Fig. 3 | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Fig. 3

From: Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India

Fig. 3

Mean change in MADRS scores with escitalopram therapy. Group 1: baseline HDRS-17 score between 18 and 23 (n = 91). Group 2—HDRS-17 score ≥ 24 (n = 57). *p value < 0.05 HDRS-17 scores at weeks 4, 8 and 12 compared with week 0. #p value < 0.05 compared with respective scores in group 2

Back to article page